What are Bromodomain and Extra Terminal Domain (BET) Inhibitors?
Bromodomain and Extra Terminal Domain (BET) inhibitors are a class of drugs that target the bromodomains within the BET family of proteins. These proteins are involved in reading epigenetic marks, influencing gene expression, and are implicated in various diseases, including cancer, inflammation, and cardiovascular conditions. BET inhibitors have shown promise in preclinical and clinical studies for their potential therapeutic benefits.
